Please assess the completion status of the following clinical trial:

Trial Title: The GlucoPred Investigation II

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* diabetes mellitus type 1~* has read and understood the informed consent documentation and is willing to participate in the investigation and willing to sign the informed consent form~* willing to participate in the investigation using one or two GlucoPred sensors for a period of 8 days~* willing to attend 2 investigational visits with duration of up to 4 hours during the investigational period~* willing to take and record up to 16 finger-stick blood samples on Day 1 and up to 8 finger-stick blood samples daily for measuring reference values for the duration of the investigation~* Uses a blood-glucose monitoring system for self-testing on a daily basis~* Willing to use the provided blood-glucose monitoring system during the investigation~* Has access to and is willing to use a computer for downloading data and charging the sensor~Exclusion Criteria:~* not fit for the investigation due concurrent illness~* Unfit for participation for any reason judged by the investigator~* pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- GlucoPred (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).